Skip to content

Effects of Different Designs of Orthokeratology Lens on Myopia Control and Visual Quality

Effects of Different Designs of Orthokeratology Lens on Myopia Control and Visual Quality

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05192824
Enrollment
200
Registered
2022-01-14
Start date
2021-12-10
Completion date
2025-12-31
Last updated
2022-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopic Progression

Brief summary

This study was aimed to evaluate the effects of different Orthokeratology,including the size of central optical zone and the height of peripheral reverse curve, on myopia control and visual quality.

Detailed description

This study was aimed to evaluate the effects of different Orthokeratology on myopia control and visual quality. The different optical zone of Orthokeratology lens was divided into 4 groups, ranged from 5.5 mm to 6 mm. And the control group subjects with the single glasses was included. The effectiveness of Orthokeratology was measured by axial length progression. The visual quality of subjects was evaluated by a questionnaire, contrast sensitivity and wavefront aberration.

Interventions

The intervention was according to the design of different optical zone and peripheral reverse curve

Sponsors

Tianjin Eye Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
8 Years to 13 Years
Healthy volunteers
Yes

Inclusion criteria

* Myopia: between -1.00D and 4.00D in both eyes * Astigmatism: \<1.5D for with-the-rule astigmatism, \<1.00D for the against-the-rule astigmatism * Visual acuity: the best corrected vision acuity(BCVA)≥20/20 in both eyes * Subjects that volunteer to participate in the clinical trial and sign informed consent

Exclusion criteria

* Contraindications of wearing Ortho-K. * Diagnosis of strabismus, amblyopia and other refractive development of the eye or systemic diseases. * Any type of strabismus or amblyopia * Systemic condition which might affect refractive development (for example, Down syndrome, Marfan's syndrome) * Ocular conditions which might affect the refractive error (for example, cataract, ptosis)

Design outcomes

Primary

MeasureTime frameDescription
Changes in axial length in 2 yearsEvery 6 months for a period 2 yearsThe axial length was measured by AL-scan
Changes in Cycloplegic subjective refraction in 2 yearsEvery 6 months for a period 2 yearsThe cycloplegic subjective refraction was evaluated by optometrist

Secondary

MeasureTime frameDescription
Change in contrast sensitivity as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months)baseline, postoperative 6 months, 12 months, 18 months and 24 monthsContrast sensitivity measured by Stereo optical 6500
Change in choroidal thickness captured by Optical Coherent Tomographer (OCT) as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months)baseline, postoperative 6 months, 12 months, 18 months and 24 monthschoroidal thickness captured by Optical Coherent Tomographer (OCT) and measured using a customized software
Change in Corneal epithelial thickness captured by Optical Coherent Tomographer (OCT) as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months)baseline, postoperative 6 months, 12 months, 18 months and 24 monthsCorneal epithelial thickness captured by Optical Coherent Tomographer (OCT) customized software
Change in visual questionnaire as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months)baseline, postoperative 6 months, 12 months, 18 months and 24 monthsThe symptoms score measured by a visual questionnaire, each symptom was evaluated on a scale of 0 to 10.
Change in peripheral refraction as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months)baseline, postoperative 6 months, 12 months, 18 months and 24 monthsPeripheral refraction measured by multispectral refraction topography
Change in corneal surface regularity index (SRI) as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months)baseline, postoperative 6 months, 12 months, 18 months and 24 monthsThe corneal surface regularity index (SRI) was measured by Corneal Topography.
Change in corneal surface asymmetry index (SAI) as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months)baseline, postoperative 6 months, 12 months, 18 months and 24 monthsThe corneal surface asymmetry index (SAI) was measured by Corneal Topography.
Change in corneal biomechanics parameters (SSI) as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months)baseline, postoperative 6 months, 12 months, 18 months and 24 monthsCorneal response parameters(SSI) was evaluated by Corvis ST.
Change in High-order aberrations (HOAs) in microns as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months)baseline, postoperative 6 months, 12 months, 18 months and 24 monthsOcular aberration measured by Zeiss i. Profiler Plus aberrometer

Countries

China

Contacts

Primary ContactShuxian Zhang, MD
xindewo2006@163.com+8618630996574

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026